Macrogen operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Macrogen with three other
companies in this sector in South Korea:
Seoulin Bioscience Company Limited
sales of 41.63 billion Korean Won [US$37.01 million]
of which 97%
Medipost Co Ltd
(37.57 billion Korean Won [US$33.40 million]
of which 64%
was Umbilical Cord Blood), and
Naturalendo Tech Co Ltd
(44.51 billion Korean Won [US$39.57 million]
During the year ended December of 2015, sales at
Macrogen were 79.53 billion Korean Won (US$70.71 million).
increase of 46.9%
versus 2014, when the company's sales were 54.13 billion Korean Won.
This was the fifth consecutive year of sales increases at Macrogen
(and since 2010, sales have increased a total of 243%).